EUVIMEDEUVIMED entdecken
Crossref

Subtle radiographic progression at 6 months can be detected using automated quantitative software in rheumatoid arthritis while receiving tocilizumab

Taichi Okino, Yafei Ou, Masayuki Ikebe, Akira Furusaki, Akira Sagawa, Masaru Kato, Tatsuya Atsumi, Kenneth Sutherland, Tamotsu Kamishima iD

Modern Rheumatology · 2024

DOI: 10.1093/mr/roae047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Taichi Okino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Technology, Sapporo City General Hospital, Hokkaido, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antibodies, Monoclonal, Humanized, Disease Progression, Antirheumatic Agents. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We investigated whether our in-house software equipped with partial image phase-only correlation (PIPOC) can detect subtle radiographic joint space narrowing (JSN) progression at 6 months and predict JSN progression in rheumatoid arthritis (RA) patients receiving Tocilizumab.

Methods

The study included 39 RA patients who were treated with Tocilizumab. Radiological progression of the finger joints was evaluated according to the Genant-modified Sharp score (GSS) at 0, 6, and 12 months.

Results

The success rate of the software for joint space width (JSW) measurement was 96.8% (449/464). The 0–12-month JSW change by the software was significantly greater in joints with the 0–6-month PIPOC (+) group than the 0–6-month PIPOC (–) group (P < 0.001). The 0–12-month JSW change by the software was 0–12 month GSS (+) than with 0–12 month GSS (–) (P = 0.02). Here, ‘(+)’ indicates the JSN progression during the follow-up period. Linear regression tests showed significant correlations between the 0–6 month and the 0–12 month PIPOC in the left second and third metacarpophalangeal joints (R2 = 0.554 and 0.420, respectively).

Conclusions

Our in-house software equipped with PIPOC could predict subsequent JSN progression with only short-term observations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntibodies, Monoclonal, HumanizedDisease ProgressionAntirheumatic AgentsSoftwareHumansFemaleMaleMiddle AgedAgedAdultFinger JointSeverity of Illness Index

Stichwörter der Autor:innen

Finger jointjoint space narrowingradiographyrheumatoid arthritissoftware

Substanzen

Antibodies, Monoclonal, HumanizedtocilizumabAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Radiological Technology, Sapporo City General Hospital, Hokkaido, Japan.
  • Research Center for Integrated Quantum Electronics, Hokkaido University, Hokkaido, Japan.
  • Sagawa Akira Rheumatology Clinic, Hokkaido, Japan.
  • Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine and Faculty of Medicine, Hokkaido University, Hokkaido, Japan.
  • Global Center for Biomedical Science and Engineering, Hokkaido University, Hokkaido, Japan.
  • Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan.

ORCID-Profile: Tamotsu Kamishima

Zitieren

APA

Okino, T., Ou, Y., Ikebe, M., Furusaki, A., Sagawa, A., Kato, M., Atsumi, T., Sutherland, K., & Kamishima, T. (2024). Subtle radiographic progression at 6 months can be detected using automated quantitative software in rheumatoid arthritis while receiving tocilizumab. Modern Rheumatology. https://doi.org/10.1093/mr/roae047

Vancouver

Okino T, Ou Y, Ikebe M, Furusaki A, Sagawa A, Kato M, et al. Subtle radiographic progression at 6 months can be detected using automated quantitative software in rheumatoid arthritis while receiving tocilizumab. Modern Rheumatology. 2024. doi:10.1093/mr/roae047

BibTeX
@article{Okino2024,
  author = {Okino, Taichi and Ou, Yafei and Ikebe, Masayuki and Furusaki, Akira and Sagawa, Akira and Kato, Masaru and Atsumi, Tatsuya and Sutherland, Kenneth and Kamishima, Tamotsu},
  title = {Subtle radiographic progression at 6 months can be detected using automated quantitative software in rheumatoid arthritis while receiving tocilizumab},
  journal = {Modern Rheumatology},
  year = {2024},
  doi = {10.1093/mr/roae047}
}
Kostenlos starten →